Patent Application
20100023082
Implantable medical devices (IMDs) include devices designed to be implanted into a patient or subject. Some examples of these devices include cardiac function management (CFM) devices such as implantable pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs), and devices that include a combination of such capabilities. The devices can be used to treat patients using electrical or other therapy, or to aid a physician or caregiver in patient diagnosis through internal monitoring of a patient's condition. The devices may include one or more electrodes in communication with one or more sense amplifiers to monitor electrical heart activity within a patient, and often include one or more sensors to monitor one or more other internal patient parameters. Other examples of implantable medical devices include implantable diagnostic devices, implantable drug delivery systems, or implantable devices with neural stimulation capability.
Additionally, some IMDs detect events by monitoring electrical heart activity signals. In CFM devices, these events can include heart chamber expansions or contractions. By monitoring cardiac signals indicative of expansions or contractions, IMDs can detect abnormally slow heart rate, or bradycardia. The monitoring can also be used to verify that electrical pacing therapy resulted in depolarization of a heart of a subject (e.g., used for sensing an evoked response).
Some IMDs detect abnormally rapid heart rate, or tachyarrhythmia. Tachyarrhythmia includes ventricular tachycardia (VT) and supraventricular tachycardia (SVT). Tachyarrhythmia also includes rapid and irregular heart rate, or fibrillation, including ventricular fibrillation (VF). When detected, ventricular tachyarrhythmia can be terminated using high-energy shock therapy applied with an ICD. It is important for IMDs to accurately classify sensed rhythms or arrhythmias.
This document relates generally to systems, devices, and methods for monitoring cardiac electrophysiological parameters of a patient or subject. Episodes of ventricular tachyarrhythmia are also monitored. In example 1, an apparatus includes an implantable sensor and a processor. The implantable sensor is configured to provide a plurality of physiologic sensor signals of a subject. The processor is communicatively coupled to the implantable sensor and includes a feature module and a detection module. The feature module is configured to identify a feature in at least one of the sensor signals and determine a measure of quality of the feature. The measure of quality includes at least one of a measure of dispersion of the feature, a measure of regularity of a shape of a sensor signal segment comprising the feature, a number of zero-value crossings in a gradient of the sensor signal segment comprising the feature, or a number of inflection points determined in the feature. The detection module is configured to perform a morphology analysis of a subsequent portion of at least one of the sensor signals using the feature when the measure of quality of the feature satisfies a quality measure threshold.
In example 2, the measure of quality of example 1 optionally includes the measure of dispersion. The detection module is optionally configured to select a particular feature for use in the morphology analysis when the measure of dispersion of the feature is less than a dispersion measure threshold.
In example 3, the measure of quality of example 1 optionally includes the measure of regularity of the shape of the sensor signal segment comprising the feature. The detection module is optionally configured to select a particular feature for use in the morphology analysis when the measure of regularity of the shape of the sensor signal segment comprising the feature exceeds a regularity measure threshold.
In example 4, the feature module of examples 1-3 is optionally configured to identify a peak value of at least one of the sensor signals. The measure of quality optionally includes the number of zero-value crossings in a gradient of the sensor signal segment comprising the feature. The gradient is obtained near a time of occurrence of the feature. The detection module is optionally configured to select a particular feature for use in the morphology analysis when the number of zero-value crossings is less than a threshold number.
In example 5, the measure of quality of example 1 optionally includes the number of inflection points determined in the feature. The detection module is optionally configured to select a particular feature for use in the morphology analysis when the number of inflection points is less than a threshold number.
In example 6, the feature module of examples 1-5 optionally provides an indication that the measure of quality ceases to satisfy the quality measure threshold. The detection module is optionally configured to perform at least one of discontinuing using the feature in the morphology analysis, or changing a morphology threshold used in the morphology analysis.
In example 7, the feature module of examples 1-6 is optionally configured to identify a specified primary feature and a secondary feature different from the primary feature. The detection module is optionally configured to use the primary feature in the morphology analysis when the measure of quality of the primary feature exceeds a primary quality measure threshold, and use the identified secondary feature in the morphology analysis when the measure of quality of the secondary feature satisfies a secondary quality measure threshold.
In example 8, the feature module of example 1-7 is optionally configured to trend the measure of quality.
In example 9, the implantable sensor of examples 1-8 optionally includes at least one of a cardiac signal sensing circuit, an intracardiac impedance sensor circuit, a transthoracic impedance sensor circuit, a blood pressure sensing circuit, a heart sound sensor circuit, an accelerometer, or a cardiac wall motion sensor circuit.
In example 10, the feature module of examples 1-9 is optionally configured to identify the feature in at least one of the sensor signals using as the feature at least one of a maximum of the at least one sensor signal, a minimum of the at least one sensor signal, a slope of the at least one sensor signal, an area under a curve of a segment of the at least one sensor signal, a time when the at least one sensor signal reaches a specified amplitude, or an Nth moment of the at least one sensor signal, wherein N is a specified integer value.
In example 11, the apparatus of examples 1-10 optionally includes a therapy circuit, communicatively coupled to the processor, configured to deliver an electrical therapy to the subject, and a cardiac signal sensing circuit, communicatively coupled to the processor, configured to provide an electrical cardiac signal representative of sensed heart activity of the subject. The detection module is optionally configured to perform the morphology analysis to determine at least one of a pacing vector, or an evoked response sensing vector.
In example 12, the apparatus of examples 1-11 optionally includes a cardiac signal sensing circuit, communicatively coupled to the processor, configured to provide an electrical cardiac signal representative of sensed cardiac activity of the subject. The detection module is optionally configured to perform the morphology analysis to identify at least one of a detected heart rhythm, or a cardiac signal sensing vector.
In example 13, the implantable sensor of examples 1-12 is optionally included in an implantable cardiac function management (CFM) device. The implantable CFM device includes a sampling circuit, communicatively coupled to the implantable sensor, configured to provide sampled sensor signals; and a communication circuit, communicatively coupled to the sampling circuit, configured to communicate information from at least one of the sampled sensor signals to an external device. The processor is included in the external device configured to communicate with the implantable CFM device.
In example 14, a method includes receiving a plurality of implantably detected physiologic sensor signals, identifying a feature in at least one of the sensor signals using a medical device, determining a measure of quality of the feature, performing a morphology analysis of a subsequent portion of the at least one of the sensor signals using the using the feature when the measure of quality of the features satisfies a quality measure threshold, and providing an outcome of the morphology analysis to a user or process. The measure of quality includes at least one of a measure of dispersion of the feature, a measure of regularity of a shape of the sensor signal segment comprising the feature, a number of zero-value crossings in a gradient of the sensor signal segment comprising the feature, or a number of inflection points determined in the feature.
In example 15, determining the measure of quality of example 14 optionally includes determining the measure of dispersion of the feature and the method includes performing the morphology analysis when the measure of dispersion of the feature is less than a dispersion measure threshold.
In example 16, determining the measure of quality of examples 14 and 15 optionally includes determining the measure of regularity of the shape of the sensor signal comprising the feature, and the method includes performing the morphology analysis when the measure of regularity of the shape of the sensor signal exceeds a regularity measure threshold.
In example 17, identifying the feature in at least one of the sensor signals of examples 14-16 optionally includes identifying a peak value of the at least one of the sensor signals, and the gradient of the sensor signal segment comprising the feature is determined near the feature. Determining the measure of quality optionally includes determining the number of zero-value crossings in the gradient, and using the feature in the morphology analysis optionally includes using the feature in the morphology analysis when the number of zero-crossings is less than a threshold number.
In example 18, determining the measure of quality of examples 14-17 optionally includes determining the number of inflection points near the feature in the at least one sensor signal comprising the feature, and the detection module is optionally configured to use the feature in the morphology analysis when the number of inflection points is less than a threshold number.
In example 19, performing the morphology analysis of examples 14-18 optionally includes performing the morphology analysis to identify a detected heart rhythm.
In example 20, the method of claims 14-19 optionally includes, when the measure of quality of the feature ceases to satisfy the quality measure threshold, at least one of discontinuing using the feature in the morphology analysis, or changing a morphology threshold used in the morphology analysis.
In example 21, the method of examples 14-20 optionally includes changing a vector configuration of the medical device in a manner so as to improve the measure of quality. In example 22, changing the vector configuration of example 21 optionally includes changing at least one of a cardiac signal sensing vector or a pacing vector.
In example 23, identifying the feature of examples 14-22 optionally includes identifying a specified primary feature. The method of the examples optionally includes identifying a secondary feature different from the primary feature, and using the identified secondary feature to identify a detected heart rhythm when a measure of quality of the secondary feature satisfies a secondary quality measure threshold.
In example 24, identifying the feature of examples 14-23 optionally comprises identifying at least one of: a maximum of the at least one sensor signal, a minimum of the at least one sensor signal, a slope of the at least one sensor signal, an area under a curve of a segment of the at least one sensor signal, a time when the at least one sensor signal reaches a specified amplitude, or an Nth moment of the at least one sensor signal, wherein N is a specified integer value.
In example 25, the medical device used in examples 14-24 optionally comprises an external device. The method of the examples optionally includes: sampling the at least one sensor signal with an implantable medical device, communicating the sampled at least one sensor signal to the external device, and wherein performing the morphology analysis of the subsequent portion of the at least one of the sensor signals includes performing the morphology analysis using the external device.
This section is intended to provide an overview of subject matter of the present patent application. It is not intended to provide an exclusive or exhaustive explanation of the invention. The detailed description is included to provide further information about the present patent application.
In the drawings, which are not necessarily drawn to scale, like numerals may describe similar components in different views. Like numerals having different letter suffixes may represent different instances of similar components. The drawings illustrate generally, by way of example, but not by way of limitation, various embodiments discussed in the present document.
An implantable medical device (IMD) may include one or more of the features, structures, methods, or combinations thereof described herein. For example, a cardiac monitor or a cardiac stimulator may be implemented to include one or more of the advantageous features or processes described below. It is intended that such a monitor, stimulator, or other implantable or partially implantable device need not include all of the features described herein, but may be implemented to include selected features that provide for unique structures or functionality. Such a device may be implemented to provide a variety of therapeutic or diagnostic functions.
The example shown includes right atrial (RA) lead 110 having a proximal end 111 and a distal end 113. The proximal end 111 is coupled to a header connector 107 of the IMD 105. The distal end 113 is configured for placement in the RA in or near the atrial septum. The RA lead 110 may include a pair of bipolar electrodes, such as an RA tip electrode 114A and an RA ring electrode 114B. The RA electrodes 114A and 114B are incorporated into the lead body at distal end 113 for placement in or near the RA, and are each electrically coupled to IMD 105 through a conductor extending within the lead body. The RA lead is shown placed in the atrial septum, but the RA lead may be placed in or near the atrial appendage, the atrial free wall, or elsewhere.
The example shown also includes a right ventricular (RV) lead 115 having a proximal end 117 and a distal end 119. The proximal end 117 is coupled to a header connector 107. The distal end 119 is configured for placement in the RV. The RV lead 115 may include one or more of a proximal defibrillation electrode 116, a distal defibrillation electrode 118, an RV tip electrode 120A, and an RV ring electrode 120B. The defibrillation electrode 116 is generally incorporated into the lead body such as in a location suitable for supraventricular placement in the RA and/or the superior vena cava. The defibrillation electrode 118 is incorporated into the lead body near the distal end 119 such as for placement in the RV. The RV electrodes 120A and 120B may form a bipolar electrode pair and are generally incorporated into the lead body at distal end 119. The electrodes 116, 118, 120A, and 120B are each electrically coupled to IMD 105, such as through one or more conductors extending within the lead body. The proximal defibrillation electrode 116, distal defibrillation electrode 118, or an electrode formed on the can of IMD 105 allow for delivery of cardioversion or defibrillation pulses to the heart.
The RV tip electrode 120A, RV ring electrode 120B, or an electrode formed on the can of IMD 105 allow for sensing an RV electrogram signal representative of RV depolarizations and delivering RV pacing pulses. In some examples, the IMD includes a sense amplifier circuit to provide amplification and/or filtering of the sensed signal. RA tip electrode 114A, RA ring electrode 114B, or an electrode formed on the can of IMD 105 allow for sensing an RA electrogram signal representative of RA depolarizations and allow for delivering RA pacing pulses. Sensing and pacing allows the IMD 105 to adjust timing of the heart chamber contractions. In some examples, the IMD 105 can adjust the timing of ventricular depolarizations with respect to the timing of atrial depolarizations by sensing electrical signals in the RA and pacing the RV at the desired atrial-ventricular (AV) delay time.
A left ventricular (LV) lead 125 can include a coronary pacing or sensing lead that includes an elongate lead body having a proximal end 121 and a distal end 123. The proximal end 121 is coupled to a header connector 107. A distal end 123 is configured for placement or insertion in the coronary vein. The LV lead 125 may include an LV ring or tip electrode 128A and an LV ring electrode 128B. The distal portion of the LV lead 125 is configured for placement in the coronary sinus and coronary vein such that the LV electrodes 128A and 128B are placed in the coronary vein. The LV electrodes 128A and 128B may form a bipolar electrode pair and are typically incorporated into the lead body at distal end 123. Each can be electrically coupled to IMD 105 such as through one or more conductors extending within the lead body. LV tip electrode 128A, LV ring electrode 128B, or an electrode formed on the can of the IMD 105 allow for sensing an LV electrogram signal representative of LV depolarizations and delivering LV pacing pulses.
An IMD may be configured with a variety of electrode arrangements, including transvenous, epicardial electrodes (i.e., intrathoracic electrodes), and/or subcutaneous, non-intrathoracic electrodes, including can, header, and indifferent electrodes, and subcutaneous array or lead electrodes (i.e., non-intrathoracic electrodes).
The electrodes and sense amplifier circuits may be included in an implantable cardiac signal sensing circuit. A cardiac signal sensing circuit obtains a sensed electrical cardiac signal associated with a depolarization of the patient's heart. Examples of cardiac signal sensing circuits include, among other things, a subcutaneous ECG sensing circuit, an intracardiac electro-gram (EGM) sensing circuit, and a wireless ECG sensing circuit. In a subcutaneous ECG sensing circuit, electrodes are implanted beneath the skin and the ECG signal obtained is referred to as subcutaneous ECG or far-field electro-gram. In an intracardiac EGM circuit, at least one electrode is placed in or around the heart. A wireless ECG includes a plurality of electrodes to provide differential sensing of cardiac signals to approximate a surface ECG. Descriptions of wireless ECG systems are found in commonly assigned, co-pending U.S. patent application Ser. No. 10/795,126 by McCabe et al., entitled “Wireless ECG in Implantable Devices,” filed on Mar. 5, 2004, which is incorporated herein by reference in its entirety.
A morphology analysis is often used to detect a physiologic event in signals provided by sensors such as a cardiac signal sensing circuit. For example, discriminating between cardiac rhythms may include a combination of heart rate based tachyarrhythmia detection in combination with morphology based tachyarrhythmia classification. Heart rate based tachyarrhythmia detection may include a comparison of a measure of heart rate or rate interval to a corresponding threshold value programmed into the device. If the heart rate meets the criteria for tachyarrhythmia, the detection then proceeds to a morphology based rhythm classification.
A morphology-based analysis typically compares the morphological shape of a sensed cardiac depolarization to a template morphology, such as to classify a heart beat or heart rhythm. An approach to a combination heart rate and morphology based arrhythmia classification can be found in Kim et al., U.S. Patent Application Pub. No. 20070197928, “Rhythm Discrimination of Sudden Onset and One-to-One Tachyarrhythmia,” filed Feb. 17, 2006, which is incorporated herein by reference in its entirety. In such a comparison, one or more features in a sensed signal are compared to a stored template signal. A correlation value can be determined (e.g., a feature correlation coefficient (FCC)) that can provide an indication of a degree of similarity between the shape of a depolarization being examined and the shape of the template to which it is compared. The FCC can be compared to a correlation threshold value to classify the rhythm as VT or SVT (e.g., ST, atrial fibrillation (AF), atrial flutter (AFL), or atrial tachyarrhythmia). However, identifying features for such an analysis may be difficult.
In another example, a morphology analysis may be used to detect pacing capture. A pace pulse must exceed a minimum energy value, or capture threshold, to produce a heart depolarization or contraction. Capture detection allows the cardiac rhythm management system to adjust the energy level of pace pulses to correspond to the optimum energy expenditure that reliably produces a depolarization. An analysis of the morphology of a sensed signal is used to detect capture.
In certain examples, classification of a cardiac response to pacing involves sensing a cardiac response during a classification window. If a trigger feature of the cardiac signal is detected in the first classification window, a second cardiac response classification window is established. The cardiac signal is sensed in the second cardiac response classification window. The cardiac response to the pacing stimulation delivered to the chamber or combination of chambers is classified based on one or more characteristics of the cardiac signal. An approach to capture detection using sensed signal morphology is found in Myer et al., U.S. Patent Pub. No. 20050131477, “Cardiac Response Classification Using Retriggerable Classification Windows,” filed Dec. 12, 2003, which is incorporated herein in its entirety.
In some examples, classification of a cardiac response to pacing involves obtaining a captured response template. One or more features of a cardiac signal sensed following a pacing stimulation are analyzed with respect to multiple classification windows. The classification windows may be defined based on the features of the captured response template. The cardiac response to pacing may be determined from a feature of the cardiac signal and the classification window in which the feature is detected. An approach to capture detection using a captured response template and sensed signal morphology is found in Kim et al., U.S. Pat. No. 7,319,900, “Cardiac Response Classification Using Multiple Classification Windows,” filed Dec. 11, 2003, which is incorporated herein by reference in its entirety.
Usually, the same feature or set of features is used for all patients in a morphology analysis, i.e., the set of features used by the analyzing medical device is static. Yet,
In some examples, the implantable sensor is a cardiac impedance sensor. A cardiac impedance sensor senses an electrical impedance signal between electrodes interposed in the heart. For example, in
In
In some examples, the implantable sensor is a cardiac pressure sensor. An implantable cardiac pressure sensor can be used to provide a sensor signal representative of heart chamber pressure. In an example, a pressure sensor may be implanted in a coronary vessel to determine left ventricle pressure by direct measurement of coronary vessel pressure. A description of systems and methods that use such an implantable pressure sensor is found in Salo et al., U.S. Pat. No. 6,666,826, entitled “Method and Apparatus for Measuring Left Ventricular Pressure,” filed Jan. 4, 2002, which is incorporated herein by reference. Other cardiac pressure sensors examples include a right ventricle (RV) chamber pressure sensor, a pulmonary artery pressure sensor, and a left atrial chamber pressure sensor.
In some examples, the implantable sensor is a heart sound sensor circuit and the sensor signal is representative of mechanical vibrations of the heart. A description of systems and methods for monitoring heart sounds is found in U.S. patent application Ser. No. 10/334,694, entitled “Method and Apparatus for Monitoring of Diastolic Hemodynamics,” filed on Dec. 30, 2002, which is incorporated herein by reference.
In some examples, the implantable sensor includes an accelerometer and the sensor signal provided is representative of patient activity. An accelerometer can also be used to provide acceleration signals that are indicative of regional cardiac wall motion. One or more accelerometers can be incorporated into a portion of a lead positioned on or in the heart. The accelerometers detect the wall motion abnormality as an abrupt decrease in the amplitude of local cardiac accelerations. A description of systems and methods for sensing wall motion is found in the commonly assigned, co-pending U.S. patent application Ser. No. 11/135,985, entitled “Systems and Methods for Multi-Axis Cardiac Vibration Measurements,” filed May 24, 2005, which is incorporated herein by reference.
Returning to
μV=E((X−μ)N).
At block 615, a measure of quality of the feature in the sensor signals is determined. In some examples, an IMD identifies the feature and determines the measure of quality. In some examples, one or more sensor signals are sampled by the IMD. The sampled signals are communicated wirelessly to an external medical device which identifies the feature and computes or calculates the measure of quality. This may be useful in offloading processing from the IMD if several features are to be identified and used. The quality measure is then compared to a quality measure threshold.
At block 620, a morphology analysis of a subsequent portion of the at least one of the sensor signals is performed using the identified feature according to the comparison of the measure to the threshold. If the quality measure satisfies the threshold, then a morphology analysis is performed using the feature. At block 625, the outcome of such a morphology analysis is provided to a user or process. The block functions may be performed by the IMD and the external device. For example, the IMD may identify the feature, determine the quality of the feature, and perform the morphology analysis.
The outcome of the morphology analysis may be used by the IMD in another analysis, used to change the behavior of the IMD, or communicated to an external device. Alternatively, sampled sensor signals may be sent to the external device for feature identification and evaluation, and the external device communicates the feature to the IMD to perform the morphology analysis; or the external device may perform the morphology analysis and communicate the results to the MD. The external device may provide the result to a user.
The measure of quality is used to determine the usefulness of the feature in the analysis. In some examples, the measure of quality includes a measure of dispersion of the feature. The measure of dispersion may include the ranges of time and/or amplitude that provide boundaries (e.g., windows) for the peak points. In some examples, the measure of dispersion includes a number of peak points that fall outside a predefined range, or the measure may include the standard deviation of time and/or amplitude of the peak points. The identified feature is used in the morphology analysis when the dispersion measure is less than a dispersion measure threshold.
The feature may exhibit clustering that has more than one node or more than one cluster (e.g., two clusters that can each be bound within a window). In this case, one of the clusters may be used, or the feature may be discarded and not used at all.
In some examples, the measure of quality includes a measure of regularity of the feature, or conversely a measure of variability of the feature. In certain examples, the measure of regularity of the shape of the sensor signal segment comprising the feature. Examples of a measure of variability include, among other things, a variance of a fiducial representing the feature in the signal or a standard deviation of the fiducial. In some examples, the measure of quality includes a measure of regularity of the shape of the feature, such as the regularity of the width of the feature and/or the regularity of the amplitude of the feature. The identified feature is used in the morphology analysis when the measure of regularity of the shape of the feature exceeds a regularity measure threshold, or conversely when a measure of variability of the shape of the feature is less than a variability measure threshold.
In some examples, the measure of quality includes a determined number of zero-value crossings in gradients of segments of the sensor signals comprising the feature.
In some examples, the measure of quality includes a number of inflection points in the feature.
Feature point 1118 and feature point 1125 are the positive and negative peaks respectively of the sensor signal 1105. Feature point 1110 and 1115 are determined based on points 1118 and 1125. If there are other inflection points around feature points 1118 or 1125, points 1118 and 1125 may move on a beat-by-beat basis, causing additional variation in feature points 1110 and 1115. This additional variation may result in errors in the morphology analysis. The inflection points can be determined from the zero-value crossing method mentioned above, or by a turning point method. In an example of a turning point method, curvature of a sampled sensor signal is computed on a sample-by-sample basis to form a curvature signal. Turns in the original sensor signal are reflected as excursions above and below a zero axis in the computed curvature signal. Descriptions of methods that determine inflection points using a turning point method are found in Sweeney et al., U.S. Patent Pub. No. 20040267143, “Signal Compression Based on Curvature Parameters,” filed Jun. 27, 2003, which is incorporated herein by reference.
The device 1200 also includes a processor 1210. The processor 1210 is communicatively coupled to the implantable sensor 1205. Communicative coupling refers to devices arranged to communicate using electrical signals that influence the operation of the devices. In some examples, the devices are coupled directly. In some examples, the devices communicate electrical signals through intermediate devices, such as devices that include digital or analog circuits.
The processor 1210 may include a digital signal processor, application specific integrated circuit (ASIC), microprocessor, or other type of processor, interpreting or executing instructions in software or firmware. To provide the functions described herein, the processor 1210 includes modules. A module may include software, hardware, firmware or any combination thereof. For example, the module may include instructions in software executing on or interpreted by the processor 1210. Multiple functions may be performed by one or more modules.
The processor 1210 includes a feature module 1215. The feature module 1215 is configured to identify a feature in the sensor signals, and determine a measure of quality of the feature in the sensor signals. The measure of quality may include a measure of dispersion of the feature in the sensor signals, a measure of regularity of the feature in the sensor signals, a number of zero-value crossings in gradients obtained from the sensor signals, and/or a number of inflection points determined in the feature in the sensor signals. The feature module 1215 is also configured to compare the measure of quality to a quality measure threshold.
The processor 1210 also includes a detection module 1220 configured to perform a morphology analysis of subsequent sensor signals using the identified feature according to a comparison of the measure of quality to a quality measure threshold.
According to some examples, the processor 1210 is configured to recursively evaluate the features identified in the sensor signals. In some examples, the feature module 1215 trends the measure of quality of the identified feature over time. If the measure of quality no longer satisfies the quality measure threshold (e.g., the measure of quality is below an acceptable threshold value, or exceeds an allowable threshold value), the detection may remove the feature from the morphology analysis or use the feature and change (e.g., reduce if appropriate) the threshold used in the morphology analysis. For example, the detection module 1220 may perform the morphology analysis to identify a detected heart rhythm. If the quality measure fails to satisfy the quality measure threshold, the detection module 1220 may use the identified feature, but reduce a FCC correlation threshold value used to classify the detected heart rhythm. In some examples, the feature module 1215 terminates the identifying when no features are identified or no features of acceptable quality are identified within a time duration.
The feature module 1215 may identify more than one feature in the sensor signals.
In some examples, the feature module 1215 identifies a specified primary feature and a secondary feature different from the primary feature. For example, the positive peak value in window 1310 of
Adding additional features may improve the morphology analysis preformed by the detection module 1220. For example, identifying the additional features may increase the confidence level that the detected rhythm matches the template. Also, the additional features may make the analysis less susceptible to false positives due to noise.
Table 1 represents examples of features identified by the medical device. Such a table may be stored in memory of the medical device. The medical device is identifying four features in three signal waveforms. The medical device may be programmed to search for those four features in the signal waveforms. The term “F21” refers to the first feature in the second signal waveform. Not all features maybe identified in the signals. The blank entry in the table represents feature number four not being identified in the second signal waveform.
The medical device analyzes the identified features. At block 1415, it is determined if an identified feature has a measure of quality that satisfies a quality measure threshold. If so, at block 1420, the medical device may increase a count of features that have acceptable quality and are useful in an analysis (e.g., a morphology analysis) of subsequently sensed signal waveforms.
At block 1425, it is determined if all identified features in the signal wave forms have been identified. If not, the analysis continues at block 1410. If so, the table above may be reduced to the table below.
The table shows the identified features that were determined to have acceptable quality. At block 1430, the medical device performs the analysis. Features of unacceptable quality may be removed from the analysis, features of acceptable quality may be added to the analysis, or analysis parameters (e.g., measurement thresholds) may be adjusted.
Returning to
In an illustrative example, the feature module 1215 identifies features deemed useful to detect evoked response of the heart to electrical pacing therapy, and the sensing vector is an evoked response sensing vector. Detecting evoked response provides verification that the pacing therapy resulted in depolarization of a heart of a subject. In some examples, the processor 1210 changes a sensing vector to improve the measure of quality in the feature by changing the electrode configuration used in the vector.
In some examples, the device 1200 includes a therapy circuit 1225 communicatively coupled to the processor 1210. The therapy circuit 1225 delivers an electrical therapy to the subject. The detection module 1220 is configured to perform the morphology analysis to determine a pacing vector. Choosing a different vector (e.g., different combination of electrodes) to deliver therapy often provides a different area to deliver the therapy, a different direction to provide the therapy, or a different timing relationship among the possible combinations.
In some examples, the implantable sensor 1205 and the processor 1210 are included in an implantable CFM device. In some examples, the functions may be performed by more than one medical device. In certain examples, the implantable sensor 1205 is included in an implantable CFM device and the processor 1210 is included in an external device.
The system 1500 also includes an external device 1552. An example of the external device 1552 includes a CFM device programmer. The external device 1552 includes a processor 1510 and a communication circuit 1555 to communicate with another device such as the implantable CFM device.
Sampled sensor signals are communicated to the external device 1552. The processor 1510 includes a feature module 1515 to identify a feature in the sampled sensor signals and to determine a measure of quality of the feature in the sampled sensor signals. In some examples, the identified feature is communicated to the CFM device. In certain examples, the identified feature is stored in the CFM device as part of a morphology template, and the CFM device performs the morphology analysis. In certain examples, the processor 1510 of the external device 1552 includes a detection module 1520 to perform the morphology analysis of subsequent sensor signals received from the CFM device 1502.
In some examples the system 1500 includes a repeater to relay communicated data or signals on to a second external device such as a server in an advanced patient management system. The processor is included in the second external device.
The above detailed description includes references to the accompanying drawings, which form a part of the detailed description. The drawings show, by way of illustration, specific embodiments in which the invention can be practiced. These embodiments are also referred to herein as “examples.” All publications, patents, and patent documents referred to in this document are incorporated by reference herein in their entirety, as though individually incorporated by reference. In the event of inconsistent usages between this document and those documents so incorporated by reference, the usage in the incorporated reference(s) should be considered supplementary to that of this document; for irreconcilable inconsistencies, the usage in this document controls.
In this document, the terms “a” or “an” are used, as is common in patent documents, to include one or more than one, independent of any other instances or usages of “at least one” or “one or more.” In this document, the term “or” is used to refer to a nonexclusive or, such that “A or B” includes “A but not B.” “B but not A,” and “A and B,” unless otherwise indicated. In the appended claims, the terms “including” and “in which” are used as the plain-English equivalents of the respective terms “comprising” and “wherein.” Also, in the following claims, the terms “including” and “comprising” are open-ended, that is, a system, device, article, or process that includes elements in addition to those listed after such a term in a claim are still deemed to fall within the scope of that claim. Moreover, in the following claims, the terms “first,” “second,” and “third,” etc. are used merely as labels, and are not intended to impose numerical requirements on their objects.
Method examples described herein can be machine or computer-implemented at least in part. Some examples can include a computer-readable medium or machine-readable medium encoded with instructions operable to configure an electronic device to perform methods as described in the above examples. An implementation of such methods can include code, such as microcode, assembly language code, a higher-level language code, or the like. Such code can include computer readable instructions for performing various methods. The code can form portions of computer program products. Further, the code can be tangibly stored on one or more volatile or non-volatile computer-readable media during execution or at other times. These computer-readable media can include, but are not limited to, hard disks, removable magnetic disks, removable optical disks (e.g., compact disks and digital video disks), magnetic cassettes, memory cards or sticks, random access memories (RAM's), read only memories (ROM's), and the like.
The above description is intended to be illustrative, and not restrictive. For example, the above-described examples (or one or more aspects thereof) may be used in combination with each other. Other embodiments can be used, such as by one of ordinary skill in the art upon reviewing the above description. The Abstract is provided to comply with 37 C.F.R. §1.72(b), to allow the reader to quickly ascertain the nature of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. Also, in the above Detailed Description, various features may be grouped together to streamline the disclosure. This should not be interpreted as intending that an unclaimed disclosed feature is essential to any claim. Rather, inventive subject matter may lie in less than all features of a particular disclosed embodiment. Thus, the following claims are hereby incorporated into the Detailed Description, with each claim standing on its own as a separate embodiment. The scope of the invention should be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled.
This application claims the benefit under 35 U.S.C. 119(e) of U.S. Provisional Patent Application Ser. No. 61/082,732, filed on Jul. 22, 2008, which is incorporated herein by reference in it entirety.
| Number | Date | Country | |
|---|---|---|---|
| 61082732 | Jul 2008 | US |
